Correction to “Statin therapy and risk of Alzheimer's and age‐related neurodegenerative diseases”

In Figure 2B, there was an error in the table where the values for risk reduction (RR) (95% confidence interval [CI]) of simvastatin for dementia and multiple Sclerosis (MS) were mistakenly duplicated.The correct value for simvastatin and risk of dementia is 0.59 (0.56-0.62), whereas the risk of MS was correctly presented as 0.45 (0.33-0.61).The correction in the table within Figure 2B does not change the statistical significance.Figure 2B has been updated to reflect the correct RR (95% CI) value for dementia associated with simvastatin and to address a publication-related adjustment to the X axis of Figure 2B.We sincerely apologize for the error in the RR value for dementia in the table within Figure 2B.